Compile Data Set for Download or QSAR
maximum 50k data
Found 52 with Last Name = 'bohno-mikami' and Initial = 'a'
TargetCytochrome P450 4F2(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591500(CHEMBL5195099)
Affinity DataIC50:  6.5nMAssay Description:Inhibition of human recombinant CYP4F2 using Luciferin-4F2/3 as substrate incubated for 60 mins in presence of NADPH regenerating system by luminesce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 4F2(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591501(CHEMBL5183418)
Affinity DataIC50:  15nMAssay Description:Inhibition of human recombinant CYP4F2 using Luciferin-4F2/3 as substrate incubated for 60 mins in presence of NADPH regenerating system by luminesce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 4F2(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591496(CHEMBL5204432)
Affinity DataIC50:  17nMAssay Description:Inhibition of human recombinant CYP4F2 using Luciferin-4F2/3 as substrate incubated for 60 mins in presence of NADPH regenerating system by luminesce...More data for this Ligand-Target Pair
In DepthDetails PubMed
TargetCytochrome P450 4A11(Homo sapiens)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591496(CHEMBL5204432)
Affinity DataIC50:  19nMAssay Description:Inhibition of human recombinant CYP4A11 using Luciferin-4A as substrate incubated for 60 mins in presence of NADPH regenerating system by luminescenc...More data for this Ligand-Target Pair
In DepthDetails PubMed
TargetCytochrome P450 4F2(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591519(CHEMBL5174407)
Affinity DataIC50:  19nMAssay Description:Inhibition of human recombinant CYP4F2 using Luciferin-4F2/3 as substrate incubated for 60 mins in presence of NADPH regenerating system by luminesce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 4F2(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591499(CHEMBL5173608)
Affinity DataIC50:  21nMAssay Description:Inhibition of human recombinant CYP4F2 using Luciferin-4F2/3 as substrate incubated for 60 mins in presence of NADPH regenerating system by luminesce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 4A11(Homo sapiens)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591520(CHEMBL5169535)
Affinity DataIC50:  29nMAssay Description:Inhibition of human recombinant CYP4A11 using Luciferin-4A as substrate incubated for 60 mins in presence of NADPH regenerating system by luminescenc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 4F2(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591520(CHEMBL5169535)
Affinity DataIC50:  36nMAssay Description:Inhibition of human recombinant CYP4F2 using Luciferin-4F2/3 as substrate incubated for 60 mins in presence of NADPH regenerating system by luminesce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 4A11(Homo sapiens)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591505(CHEMBL5199278)
Affinity DataIC50:  38nMAssay Description:Inhibition of human recombinant CYP4A11 using Luciferin-4A as substrate incubated for 60 mins in presence of NADPH regenerating system by luminescenc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 4F2(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591510(CHEMBL5206230)
Affinity DataIC50:  40nMAssay Description:Inhibition of human recombinant CYP4F2 using Luciferin-4F2/3 as substrate incubated for 60 mins in presence of NADPH regenerating system by luminesce...More data for this Ligand-Target Pair
In DepthDetails PubMed
TargetCytochrome P450 4A11(Homo sapiens)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591506(CHEMBL5189943)
Affinity DataIC50:  41nMAssay Description:Inhibition of human recombinant CYP4A11 using Luciferin-4A as substrate incubated for 60 mins in presence of NADPH regenerating system by luminescenc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 4F2(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591497(CHEMBL5192170)
Affinity DataIC50:  44nMAssay Description:Inhibition of human recombinant CYP4F2 using Luciferin-4F2/3 as substrate incubated for 60 mins in presence of NADPH regenerating system by luminesce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 4A11(Homo sapiens)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591502(CHEMBL5205521)
Affinity DataIC50:  63nMAssay Description:Inhibition of human recombinant CYP4A11 using Luciferin-4A as substrate incubated for 60 mins in presence of NADPH regenerating system by luminescenc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 4F2(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591518(CHEMBL5172100)
Affinity DataIC50:  63nMAssay Description:Inhibition of human recombinant CYP4F2 using Luciferin-4F2/3 as substrate incubated for 60 mins in presence of NADPH regenerating system by luminesce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 4F2(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591498(CHEMBL5180285)
Affinity DataIC50:  66nMAssay Description:Inhibition of human recombinant CYP4F2 using Luciferin-4F2/3 as substrate incubated for 60 mins in presence of NADPH regenerating system by luminesce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 4F2(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591504(CHEMBL5208981)
Affinity DataIC50:  69nMAssay Description:Inhibition of human recombinant CYP4F2 using Luciferin-4F2/3 as substrate incubated for 60 mins in presence of NADPH regenerating system by luminesce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 4A11(Homo sapiens)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591508(CHEMBL5192567)
Affinity DataIC50:  70nMAssay Description:Inhibition of human recombinant CYP4A11 using Luciferin-4A as substrate incubated for 60 mins in presence of NADPH regenerating system by luminescenc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 4F2(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591517(CHEMBL5183091)
Affinity DataIC50:  73nMAssay Description:Inhibition of human recombinant CYP4F2 using Luciferin-4F2/3 as substrate incubated for 60 mins in presence of NADPH regenerating system by luminesce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 4F2(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591503(CHEMBL5195431)
Affinity DataIC50:  96nMAssay Description:Inhibition of human recombinant CYP4F2 using Luciferin-4F2/3 as substrate incubated for 60 mins in presence of NADPH regenerating system by luminesce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 4F2(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591516(CHEMBL5199197)
Affinity DataIC50:  110nMAssay Description:Inhibition of human recombinant CYP4F2 using Luciferin-4F2/3 as substrate incubated for 60 mins in presence of NADPH regenerating system by luminesce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 4A11(Homo sapiens)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591510(CHEMBL5206230)
Affinity DataIC50:  140nMAssay Description:Inhibition of human recombinant CYP4A11 using Luciferin-4A as substrate incubated for 60 mins in presence of NADPH regenerating system by luminescenc...More data for this Ligand-Target Pair
In DepthDetails PubMed
TargetCytochrome P450 4A11(Homo sapiens)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591497(CHEMBL5192170)
Affinity DataIC50:  160nMAssay Description:Inhibition of human recombinant CYP4A11 using Luciferin-4A as substrate incubated for 60 mins in presence of NADPH regenerating system by luminescenc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 4F2(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591514(CHEMBL5184859)
Affinity DataIC50:  170nMAssay Description:Inhibition of human recombinant CYP4F2 using Luciferin-4F2/3 as substrate incubated for 60 mins in presence of NADPH regenerating system by luminesce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 4F2(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591509(CHEMBL5191778)
Affinity DataIC50:  180nMAssay Description:Inhibition of human recombinant CYP4F2 using Luciferin-4F2/3 as substrate incubated for 60 mins in presence of NADPH regenerating system by luminesce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 4A11(Homo sapiens)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591504(CHEMBL5208981)
Affinity DataIC50:  210nMAssay Description:Inhibition of human recombinant CYP4A11 using Luciferin-4A as substrate incubated for 60 mins in presence of NADPH regenerating system by luminescenc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 4F2(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591515(CHEMBL5203135)
Affinity DataIC50:  220nMAssay Description:Inhibition of human recombinant CYP4F2 using Luciferin-4F2/3 as substrate incubated for 60 mins in presence of NADPH regenerating system by luminesce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 4A11(Homo sapiens)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591509(CHEMBL5191778)
Affinity DataIC50:  220nMAssay Description:Inhibition of human recombinant CYP4A11 using Luciferin-4A as substrate incubated for 60 mins in presence of NADPH regenerating system by luminescenc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 4A11(Homo sapiens)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591498(CHEMBL5180285)
Affinity DataIC50:  260nMAssay Description:Inhibition of human recombinant CYP4A11 using Luciferin-4A as substrate incubated for 60 mins in presence of NADPH regenerating system by luminescenc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 4F2(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591502(CHEMBL5205521)
Affinity DataIC50:  260nMAssay Description:Inhibition of human recombinant CYP4F2 using Luciferin-4F2/3 as substrate incubated for 60 mins in presence of NADPH regenerating system by luminesce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 4A11(Homo sapiens)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591517(CHEMBL5183091)
Affinity DataIC50:  310nMAssay Description:Inhibition of human recombinant CYP4A11 using Luciferin-4A as substrate incubated for 60 mins in presence of NADPH regenerating system by luminescenc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 4A11(Homo sapiens)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591499(CHEMBL5173608)
Affinity DataIC50:  370nMAssay Description:Inhibition of human recombinant CYP4A11 using Luciferin-4A as substrate incubated for 60 mins in presence of NADPH regenerating system by luminescenc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 4A11(Homo sapiens)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591501(CHEMBL5183418)
Affinity DataIC50:  390nMAssay Description:Inhibition of human recombinant CYP4A11 using Luciferin-4A as substrate incubated for 60 mins in presence of NADPH regenerating system by luminescenc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 4A11(Homo sapiens)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591514(CHEMBL5184859)
Affinity DataIC50:  410nMAssay Description:Inhibition of human recombinant CYP4A11 using Luciferin-4A as substrate incubated for 60 mins in presence of NADPH regenerating system by luminescenc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 4F2(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591495(CHEMBL5181522)
Affinity DataIC50:  510nMAssay Description:Inhibition of human recombinant CYP4F2 using Luciferin-4F2/3 as substrate incubated for 60 mins in presence of NADPH regenerating system by luminesce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 4A11(Homo sapiens)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591516(CHEMBL5199197)
Affinity DataIC50:  530nMAssay Description:Inhibition of human recombinant CYP4A11 using Luciferin-4A as substrate incubated for 60 mins in presence of NADPH regenerating system by luminescenc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 4A11(Homo sapiens)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591515(CHEMBL5203135)
Affinity DataIC50:  610nMAssay Description:Inhibition of human recombinant CYP4A11 using Luciferin-4A as substrate incubated for 60 mins in presence of NADPH regenerating system by luminescenc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 4A11(Homo sapiens)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591519(CHEMBL5174407)
Affinity DataIC50:  640nMAssay Description:Inhibition of human recombinant CYP4A11 using Luciferin-4A as substrate incubated for 60 mins in presence of NADPH regenerating system by luminescenc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 4F2(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591507(CHEMBL5195609)
Affinity DataIC50:  640nMAssay Description:Inhibition of human recombinant CYP4F2 using Luciferin-4F2/3 as substrate incubated for 60 mins in presence of NADPH regenerating system by luminesce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 4F2(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591508(CHEMBL5192567)
Affinity DataIC50:  640nMAssay Description:Inhibition of human recombinant CYP4F2 using Luciferin-4F2/3 as substrate incubated for 60 mins in presence of NADPH regenerating system by luminesce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 4F2(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591505(CHEMBL5199278)
Affinity DataIC50:  710nMAssay Description:Inhibition of human recombinant CYP4F2 using Luciferin-4F2/3 as substrate incubated for 60 mins in presence of NADPH regenerating system by luminesce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 4F2(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591506(CHEMBL5189943)
Affinity DataIC50:  730nMAssay Description:Inhibition of human recombinant CYP4F2 using Luciferin-4F2/3 as substrate incubated for 60 mins in presence of NADPH regenerating system by luminesce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 4A11(Homo sapiens)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591507(CHEMBL5195609)
Affinity DataIC50:  860nMAssay Description:Inhibition of human recombinant CYP4A11 using Luciferin-4A as substrate incubated for 60 mins in presence of NADPH regenerating system by luminescenc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 4A11(Homo sapiens)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591518(CHEMBL5172100)
Affinity DataIC50:  1.30E+3nMAssay Description:Inhibition of human recombinant CYP4A11 using Luciferin-4A as substrate incubated for 60 mins in presence of NADPH regenerating system by luminescenc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 4A11(Homo sapiens)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591500(CHEMBL5195099)
Affinity DataIC50:  1.60E+3nMAssay Description:Inhibition of human recombinant CYP4A11 using Luciferin-4A as substrate incubated for 60 mins in presence of NADPH regenerating system by luminescenc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 4A11(Homo sapiens)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591503(CHEMBL5195431)
Affinity DataIC50:  6.00E+3nMAssay Description:Inhibition of human recombinant CYP4A11 using Luciferin-4A as substrate incubated for 60 mins in presence of NADPH regenerating system by luminescenc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 4A11(Homo sapiens)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591495(CHEMBL5181522)
Affinity DataIC50:  7.40E+3nMAssay Description:Inhibition of human recombinant CYP4A11 using Luciferin-4A as substrate incubated for 60 mins in presence of NADPH regenerating system by luminescenc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 4A11(Homo sapiens)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591511(CHEMBL5182293)
Affinity DataIC50:  9.30E+3nMAssay Description:Inhibition of human recombinant CYP4A11 using Luciferin-4A as substrate incubated for 60 mins in presence of NADPH regenerating system by luminescenc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 4F2(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591511(CHEMBL5182293)
Affinity DataIC50:  1.10E+4nMAssay Description:Inhibition of human recombinant CYP4F2 using Luciferin-4F2/3 as substrate incubated for 60 mins in presence of NADPH regenerating system by luminesce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 4F2(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591512(CHEMBL5170975)
Affinity DataIC50:  1.20E+4nMAssay Description:Inhibition of human recombinant CYP4F2 using Luciferin-4F2/3 as substrate incubated for 60 mins in presence of NADPH regenerating system by luminesce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 4A11(Homo sapiens)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591513(CHEMBL5181516)
Affinity DataIC50:  1.90E+4nMAssay Description:Inhibition of human recombinant CYP4A11 using Luciferin-4A as substrate incubated for 60 mins in presence of NADPH regenerating system by luminescenc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
Displayed 1 to 50 (of 52 total ) | Next | Last >>
Jump to: